Outlook Therapeutics

1. ONS-5010/LYTENAVA corporate update2H 2026ONS-5010/LYTENAVA corporate update, 2H 2026, notable
2. OTLK corporate updateDec 31, 2026OTLK corporate update, Dec 31, 2026, routine
3. Avondale March 2025 Note corporateDec 31, 2026Avondale March 2025 Note corporate, Dec 31, 2026, routine
4. ONS-5010/LYTENAVA commercial launch2027ONS-5010/LYTENAVA commercial launch, 2027, notable
5. OTLK corporate updateJun 16, 2027OTLK corporate update, Jun 16, 2027, routine
6. Atlas March 2026 Note corporateJun 16, 2027Atlas March 2026 Note corporate, Jun 16, 2027, routine
7. financing corporate updateJun 16, 2027financing corporate update, Jun 16, 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.